By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Selecta Biosciences, Inc. 

480 Arsenal Street
Building One
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-923-1400 Fax: 617-924-3454


SEARCH JOBS








Company News
Selecta And Genethon Collaborate To Create Next Generation Gene Therapies Using Selecta’s Synthetic Vaccine Particle Platform 5/13/2015 10:08:43 AM
Sanofi (SAN.PA) Adds Celiac Disease to the Menu With $300 Million Selecta Bet 5/13/2015 5:59:40 AM
Selecta Biosciences, Inc. To Webcast Presentation At Needham & Company’s 14th Annual Healthcare Conference 4/6/2015 10:27:12 AM
Selecta Biosciences, Inc. And Skolkovo Foundation Collaboration To Develop A Synthetic Vaccine Particle In The Field Of Immuno-Oncology 12/23/2014 10:30:41 AM
Selecta Biosciences, Inc., Juvenile Diabetes Research Foundation And Sanofi (SAN.PA) Extend Collaboration To Develop A Synthetic Vaccine Particle Immunotherapy For Type 1 Diabetes 10/15/2014 9:41:07 AM
Selecta Biosciences, Inc. Announces More Than $20 Million In Equity Funding 10/15/2014 6:29:47 AM
3SBio Inc. (SSRX) Exclusively Licenses Pegsiticase (Uricase PEG-20) To Selecta Biosciences, Inc. To Develop Drug Candidate To Treat Gout 6/18/2014 9:20:48 AM
Selecta Biosciences, Inc. Accelerates Immune Tolerance Therapeutics And Announces New Product Candidate, SEL-212, For Refractory And Tophaceous Gout 6/17/2014 12:56:44 PM
Selecta Biosciences, Inc. Enters Into Exclusive License Agreement With 3SBio Inc. (SSRX) To Develop Drug Candidate To Treat Gout 6/17/2014 11:29:08 AM
Selecta Biosciences, Inc. To Accelerate Program For Novel Dual Action Vaccine For Malaria 6/17/2014 10:11:42 AM
123
//-->